Fundraising Fox
/Companies
Sign in

2A Biosciences

Santa Monica, US · Founded 2023 · 10 employees on LinkedIn · 5 known investors

Find your way into 2A Biosciences

Sign up to see every warm intro you have to 2A Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 2A Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

2AB BioscienceS develops first-in-class small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders. The platform uses structure-guided design to create therapies aimed at tissue regeneration, inflammation resolution, and neural circuit restoration.

BiotechDeep TechDigital HealthEdTechHealthtechMedical Devices

Founders & leadership

2A Biosciences was founded in 2023 by Alex Speiser, Charles Nichols, PhD, David Nichols, PhD, and Tim Foster, PhD.

ASAlex Speiser
Alex SpeiserCo-Founder & Chief Executive OfficerAlex Speiser holds a B.A. from Wesleyan University and has served as Director of Corporate Development at Eleusis and VP of Business Development at G.S. Power Partners. He is co-founder and CEO of 2A Biosciences, which develops small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders.
CNCharles Nichols, PhD
Charles Nichols, PhDCo-Founder & Chief Science Officer
DNDavid Nichols, PhD
David Nichols, PhDCo-Founder & Head of Chemistry
TF
Tim Foster, PhDCo-Founder & Head of Translational Discovery

Board

GD
Gopal DasBoard director

Investors · 5

LIONHEART VENTURESlisted by LIONHEART VENTURESSan Francisco

How we know: LIONHEART VENTURES's portfolio page · Not right? Tell us

Palo Santo VClisted by Palo Santo VC

How we know: Palo Santo VC's portfolio page · Not right? Tell us

Tabula Rasa Ventureslisted by Tabula Rasa Ventures$50K – $1M

How we know: Tabula Rasa Ventures's portfolio page · Not right? Tell us

What If Ventureslisted by What If VenturesFriscovia Stephen Hays · inferred

How we know: What If Ventures's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$3.8M disclosed across 1 round · 2023

▶$3.8MraisedJul 2023 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Gopal DasDirector
  • Alexander SpeiserExecutive Officer, Director
  • Charles David NicholsExecutive Officer, Director
  • Timothy Paul FosterDirector, Executive Officer
  • David Earl NicholsExecutive Officer, Director
Offering amount
$5.5M
Amount sold
$3.8M
First sale
Mar 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does 2A Biosciences do?
2AB BioscienceS develops first-in-class small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders. The platform uses structure-guided design to create therapies aimed at tissue regeneration, inflammation resolution, and neural circuit restoration.
Who founded 2A Biosciences?
2A Biosciences was founded by Alex Speiser, Charles Nichols, PhD, David Nichols, PhD, Tim Foster, PhD in 2023.
Who are 2A Biosciences's investors?
2A Biosciences's investors include Gaingels, LIONHEART VENTURES, Palo Santo VC, Tabula Rasa Ventures, What If Ventures.
How much funding has 2A Biosciences raised?
2A Biosciences has disclosed $3.8M raised across 1 round.
Where is 2A Biosciences headquartered?
2A Biosciences is headquartered in Santa Monica, US.